Register for Your Free Live Webinar Now:

"Translating Lab Data into Market Strategy"

Join this live webinar to learn more.

The therapeutic landscape is shifting—and biomarkers are at the center of this transformation. In this exclusive session, we’ll spotlight high-impact protein targets including FOLR1, HER2, Claudin 18.2, cMET, FGFR2b, DLL3, and Trop2. Join us to discover:

• How novel biomarkers are accelerating precision strategies across therapeutic areas
• The latest approaches for unlocking commercial advantage, and why choosing the right lab partner is critical for success
• Real-world insights to translate biomarker discovery into market impact
• And more

Offered Free by: NeoGenomics Laboratories
See All Resources from: NeoGenomics Laboratories